Suppr超能文献

序贯平行比较设计下的精确检验和渐近检验

Exact and asymptotic tests under the sequential parallel comparison design.

作者信息

Lui Kung-Jong

机构信息

Department of Mathematics and Statistics, San Diego State University, San Diego, CA, USA.

出版信息

Pharm Stat. 2018 Nov;17(6):835-845. doi: 10.1002/pst.1894. Epub 2018 Aug 23.

Abstract

When one studies treatments for psychological or mental diseases in a double-blind placebo-controlled trial with a high placebo response rate, the sequential parallel comparison design (SPCD) has been proposed elsewhere to improve power. All procedures for testing equality of treatments under the SPCD have been so far derived from large sample theory. If the trial size is small, asymptotic test procedures can be theoretically invalid. Thus, the development of an exact test procedure assuring type I error rate to be less than or equal to the nominal α-level is of use and interest. Using the conditional arguments to remove nuisance parameters, we derive two exact and one asymptotic procedures for testing equality of treatments for the SPCD. On the basis of Monte Carlo simulation, we find that all three test procedures can control type I error rate well in a variety of situations. We use the data taken from a double-blind placebo-controlled SPCD trial to assess the efficacy of a low dose (2 mg/day) of aripiprazole adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder with a history of inadequate response to prior antidepressant therapy to illustrate the use of these test procedures.

摘要

当在安慰剂反应率较高的双盲安慰剂对照试验中研究心理或精神疾病的治疗方法时,其他地方已提出序贯平行比较设计(SPCD)以提高检验效能。到目前为止,SPCD下检验治疗方法等效性的所有程序均源自大样本理论。如果试验规模较小,渐近检验程序在理论上可能无效。因此,开发一种确保I型错误率小于或等于名义α水平的精确检验程序是有用且有意义的。利用条件论证来消除干扰参数,我们推导出了用于检验SPCD治疗方法等效性的两种精确程序和一种渐近程序。基于蒙特卡罗模拟,我们发现这三种检验程序在各种情况下都能很好地控制I型错误率。我们使用来自一项双盲安慰剂对照SPCD试验的数据,来评估低剂量(2毫克/天)阿立哌唑辅助抗抑郁治疗对既往抗抑郁治疗反应不佳的重度抑郁症患者的疗效,以说明这些检验程序的使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验